Every SEC Form 3/4/5 on record for this filer (CIK 1870913) — 1 issuer, 80 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ANIP | ANI PHARMACEUTICALS INC | HEAD OF R&D, COO-NOVITIUM OPS · Director | 2021-11-23 → 2026-03-02 | 37 | −$63M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ANIP | 2025-08-21 | Sell | 52,988 | $90.44 | $5M | 431,920 |
| ANIP | 2025-08-20 | Sell | 47,012 | $90.27 | $4M | 484,908 |
| ANIP | 2025-08-15 | Sell | 52,990 | $87.15 | $5M | 531,920 |
| ANIP | 2025-08-14 | Sell | 47,010 | $89.48 | $4M | 584,910 |
| ANIP | 2025-05-09 | Sell | 700 | $76.83 | $53,781 | 631,920 |
| ANIP | 2024-07-18 | Sell | 2,743 | $62.00 | $170,066 | 632,620 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.